ENTITY
Daiichi Sankyo

Daiichi Sankyo (4568 JP)

140
Analysis
Health CareJapan
Daiichi Sankyo Co, Ltd is a holding company established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals.
more
24 Feb 2021 11:26

Global Fund Positioning in Japan:  Underweight and Underowned

With the Nikkei 225 index breaking 30k this month,  Global managers remain under-invested and underweight Japan versus the benchmark MSCI All...

Logo
304 Views
Share
04 Feb 2021 05:25

🇯🇵 JAPAN • Results & Revisions ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​02/​​​​​​​​​​​​​​​03 Hirose, Eisai..

Of Wednesday's 100 results announcements, 78% scored positively for earnings momentum despite trailing revenues falling by 5.7% on average and a...

Logo
221 Views
Share
02 Feb 2021 06:39

🇯🇵 JAPAN • Results & Revisions ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​02/​​​​​​​​​​​​​01 - Rohm, Shionogi..

Of Monday's 76 results announcements, 79% scored positively for earnings momentum despite trailing revenues falling by 5.2% on average and a 2.6...

Logo
208 Views
Share
01 Feb 2021 06:47

🇯🇵 JAPAN • Market + Results & Revisions Update 01/29

Thursday's Vale Traded ratio was the highest year-to-date and the third-highest since the COVID-low of 13th March 2020. Down Volume reached 'Panic'...

Logo
206 Views
Share
bullishDaiichi Sankyo
01 Nov 2020 08:48

Dai-Ichi Sankyo (4568) Buyback Dynamics

Dai-Ichi Sankyo has announced Q2 earnings, a forecast revision, and a ¥100bn buyback to pick up where it left off in 2018. This is twice as big as...

Logo
371 Views
Share
x